Aaron Ondrey

Chief Financial Officer, Mirati Therapeutics, Inc.

Companies

Rocket Pharmaceuticals Inc.Chief financial officer Apr 3, 2024 to now¹
Mirati Therapeutics, Inc.Chief financial officer Sep 12, 2023 to Jan 23, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Rocket Pharmaceuticals Inc. RCKT128,173 shares³$302.5K at $2.36Jul 3, 2025
Mirati Therapeutics, Inc.0 shares⁴Jan 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 3, 2025Sold 1,477 shares at $2.88 of Rocket Pharmaceuticals Inc.³
Apr 4, 2025Sold 7,489 shares at $5.29 of Rocket Pharmaceuticals Inc.⁵
Feb 11, 2025Granted 90,358 shares of Rocket Pharmaceuticals Inc.⁶
Apr 1, 2024Granted 46,781 shares of Rocket Pharmaceuticals Inc.⁷
Jan 23, 2024Returned to company 17,021 shares of Mirati Therapeutics, Inc.⁴
Jan 23, 2024Returned to company 21,138 shares of Mirati Therapeutics, Inc.⁴
Jan 23, 2024Returned to company 1,302 shares of Mirati Therapeutics, Inc.⁴
Dec 29, 2023Granted 17,021 shares at $58.75 of Mirati Therapeutics, Inc.⁸
Sep 8, 2023Granted 8,412 shares at $35.66 of Mirati Therapeutics, Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRocket Pharmaceuticals Inc., Chief financial officer
2
SEC EDGARMirati Therapeutics, Inc., Chief financial officer
3
SEC EDGARRocket Pharmaceuticals Inc. shares after the filing of Jul 3, 2025
4
SEC EDGARMirati Therapeutics, Inc. shares after the filing of Jan 23, 2024
5
SEC EDGARForm 4 filed Apr 8, 2025
6
SEC EDGARForm 4 filed Feb 13, 2025
7
SEC EDGARForm 4 filed Apr 3, 2024
8
SEC EDGARForm 4 filed Jan 3, 2024
9
SEC EDGARForm 4 filed Sep 12, 2023